The main ingredient of this product is ambrisentan
Chemical Name: (+)-(2S)-2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic acid
Molecular Formula: C22H22N2O4
Molecular Weight: 378.42
This product is a yellow film-coated tablet, which is white or off-white after removal of the film coat.
This product is indicated for the treatment of patients with pulmonary arterial hypertension of WHO class II-III symptoms (WHO group 1) to improve exercise ability and delay clinical worsening. Studies establishing effectiveness of ambrisentan included patients with etiologies of idiopathic or heritable PAH (64%) or PAH associated connective tissue disease (32%).
【Dosage and Administration】
Treatment with this drug must be initiated and supervised by up physician experienced in the treatment of pulmonary hypertension.